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Abstract 
Cleft lip with or without palate (CLP) or isolated cleft palate (CP) are common human 
developmental malformations with a complex aetiology that reflects a failure of normal 
facial development. VAX1 encodes a homeobox-containing transcription factor identified 
as a candidate gene for CLP in human populations, with targeted deletion in mice 
associated with multiple anomalies, including disruption of the visual apparatus and basal 
forebrain, lobar holoprosencephaly and CP. We have investigated Vax1 function during 
murine palatogenesis but find no evidence for a direct role in this process. Vax1 is not 
expressed in the developing palate and mutant palatal shelves elevate above the tongue, 
demonstrating morphology and proliferation indices indistinguishable from wild type. 
However, mutant mice did have a large midline cavity originating from the embryonic 
forebrain situated beneath the floor of the hypothalamus and extending through the nasal 
cavity to expand this region and prevent approximation of the palatal shelves. Interestingly, 
despite strong expression of Vax1 in ectoderm of the medial nasal processes, the upper 
lip remained intact in mutant mice. We found further evidence of disrupted craniofacial 
morphology in Vax1 mutants, including truncation of the midface associated with reduced 
cell proliferation in forebrain neuroectoderm and frontonasal mesenchyme. Sonic 
hedgehog (Shh) signal transduction was downregulated in the mutant forebrain consistent 
with a role for Vax1 in mediating transduction of this pathway. However, Shh was also 
reduced in this region, suggestive of an Shh-Vax1 feedback loop during early development 
of the forebrain and a likely mechanism for the underlying lobar HPE. Despite significant 
associations between VAX1 and human forms of CLP we find no evidence of a direct role 
for this transcription factor in development of this region in a mutant mouse model. 
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Introduction 
Cleft lip with or without the palate (CLP) or isolated clefts of the palate (CP) are relatively 
common human congenital malformations seen with a prevalence ranging from 1:500-
2000 live births, depending upon racial background. The aetiological basis of these 
disorders is complex but reflects a failure of normal facial development mediated through 
genetic and environmental factors (Dixon et al. 2011). A number of independent studies 
have found associations between the homeobox gene VAX1 and CLP in human 
populations (Butali et al. 2013; de Aquino et al. 2013; de Araujo et al. 2016; Gowans et al. 
2016; Peng et al. 2016; Slavotinek et al. 2012; Wang et al. 2016; Wen and Lu 2016; 
Zawislak et al. 2014) and Vax genes act downstream of Sonic hedgehog (Shh) (Hallonet 
et al. 1999; Kim and Lemke 2006; Take-uchi et al. 2003; Zhao et al. 2010) and as both Fgf 
and Wnt antagonists in a number of developmental contexts (Bharti et al. 2011; Vacik et 
al. 2011). Vax1 is first expressed in the early central nervous system (CNS) (Bertuzzi et al. 
1999; Hallonet et al. 1998; Taglialatela et al. 2004) and targeted disruption in mice 
produces multiple defects in the visual apparatus, including coloboma and absence of the 
optic chiasma, accompanying growth defects in the medioventral CNS, altered axonal 
guidance and duplication of the pituitary gland (Bertuzzi et al. 1999; Bharti et al. 2011; 
Hallonet et al. 1999; Taglialatela et al. 2004). Significantly, Vax1 mutant mice also have 
lobar holoprosencephaly (HPE) and CP, although the molecular basis of these defects has 
not been investigated (Bertuzzi et al. 1999; Hallonet et al. 1999). 
HPE is a heterogeneous and complex developmental anomaly associated with 
incomplete division of the embryonic forebrain and classified as alobar, semilobar or lobar, 
depending upon the amount of cleavage within the telencephalon. A key feature of HPE is 
aberrant facial development, which can manifest as frank cyclopia or in association with 
other facial defects, including hypotelorism, single nostril, single median maxillary central 
incisor (SMMCI) and CLP (Geng and Oliver 2009). HPE has marked clinical variation, with 
notoriously poor genotypic-phenotypic correlation and wide-ranging intra-familial variability 
in humans (Ming and Muenke 2002). Moreover, increasing evidence from mouse models 
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has demonstrated the significance of multiple genetic and environmental factors that can 
influence phenotype (Heyne et al. 2016; Hong and Krauss 2012). 
Here we describe in detail the craniofacial defects associated with loss of Vax1 in 
the mouse and further investigate the role of Vax1 during palatogenesis. Vax1 was 
expressed in ectoderm of the medial nasal processes within the developing facial region, 
but transcripts were not identifiable in the secondary palate. Although, loss of Vax1 is 
associated with a fully penetrant CP, the upper lip remains intact in mutant mice. We 
provide evidence to suggest that CP occurs secondary to disruption within the CNS rather 
than a direct requirement for Vax1 during palatogenesis. We further identify reduced Shh 
signal transduction in the early ventral forebrain and reduced levels of proliferation in 
neuroectoderm of this region in mutant mice. Interestingly, loss of Vax1 in a background 
of reduced Shh activity through generation of Vax1; Gas1 compound mutant mice did not 
worsen the cleft phenotype, although the SMMCI seen in association with loss of single 
alleles reverted to complete incisor agenesis in the compound mutants. 
 
Materials and Methods 
Generation of Vax1 and Gas1 single and compound mutant mice 
All procedures were carried out in accordance with the UK Animals (Scientific Procedures) 
Act (1986) and subject to the approved protocols at King's College London. This study 
conforms with ARRIVE guidelines. Vax1 and Gas1 mice were housed in a Biological 
Services Unit, generated and maintained on a 129sv/C57BL6 background and genotyped 
as previously described (Hallonet et al. 1999; Lee et al. 2001). For Vax1; Gas1 mice both 
mutant alleles contain a LacZ, therefore genotyping involving two reactions. For the first, 
the forward primer was constructed to align against the promoter region of Gas1 
[CCGGAGAGTGGAGAAAGGAG]; the reverse primer aligned against the LacZ cassette 
[CCCCTGAGCATGATCTTCCA] to produce a 392-bp PCR product. For the second, a 350-
bp fragment of the wild type (WT) Gas1 allele deleted in the mutant was amplified using 
the forward primer [ATCTCGGCGCTTATCCAGCTCAAC] and reverse primer 
 5 
CATCGCACACGCAGTCGTTGAGCA. Timed-matings were set up such that noon of the 
day on which vaginal plugs were detected was considered embryonic day (E) 0.5. 
Pregnant females were euthanized with cervical dislocation. For all experiments, a 
minimum number of 3 WT and 3 mutant mice were compared. 
 
Histology, skeletal analysis and in situ hybridization 
Histological analysis, differential staining of bone and cartilage, radioactive and 
digoxigenin-section in situ hybridisation was conducted as previously described (Seppala 
et al. 2007); (Oommen et al. 2012). 
 
Proliferation, apoptosis and craniofacial dimensional assays 
Bromodeoxyuridine (BrdU) labeling for cell proliferation assays was carried out on 
histological sections using a Zymed BrdU Labeling and Detection Kit (Invitrogen) according 
to manufacturer instructions. Mouse embryos were labelled with BrdU via intra-peritoneal 
injection into pregnant females (5mg/100g body-weight) 2 hours prior to sacrifice. Embryos 
were fixed in 4% PFA at 4°C overnight, dehydrated in ethanol, embedded in paraffin wax, 
and sectioned at 7μm. The percentage BrdU-positive cells was calculated. 
Immunohistochemical detection of apoptotic cell death was carried out on 
histological sections using Terminal deoxynucleotidyl transferase-mediated deoxyUridine 
triPhosphate Nick End Labeling (TUNEL). TUNEL was carried out using an APOPTag® 
Plus Fluorescein In Situ Apoptosis Detection Kit (Chemicon) according to manufacturer 
instructions. 
Craniofacial dimensions were measured on histological sections using lines 
constructed from specific anatomical points (Schambra, 2008). All cell counting and linear 
measurment was conducted by one researcher blinded to experimental group on two 
separate occasions one week apart and the mean value calculated. 
 
 6 
qRT-PCR analysis 
qRT-PCR analysis of Shh, Ptch1 and Nkx2.1 expression was performed on E10.5 WT and 
Vax1-/- embryo heads. Tissue was carefully dissected from the ventral forebrain and facial 
area and immediately transferred into Trizol. cDNA was synthesized from total RNA and 
qPCR performed using SYBR® Green PCR Master Mix in an ABI Prism 7900 HT cycler 
(Applied Biosystems). A standard curve method of quantitation was used to calculate 
expression of target genes relative to the house keeping gene β-Actin. Four serial dilutions 
of cDNA (1:4) were made for the calibration curve and trend-lines were drawn using Ct 
values versus log of dilutions for each target gene and β-Actin run in triplicate with a 
correlation coefficient (R2>0.99). Relative expressions were calculated using line 
equations derived from calibration curves and obtaining ratios of target gene to β-Actin. 
For each gene, experiments were run at least three times using cDNA obtained from three 
independent RNA purifications. Data was analysed as previously described (Livak and 
Schmittgen 2001). 
 
Results 
Vax1 mutant mice have multiple craniofacial anomalies 
We investigated the craniofacial phenotype of Vax1-/- embryos from E12.5-17.5 using 
skeletal preparation and standard histology (n=4 for all stages) (Fig1A-D; E-V, 
respectively). Consistent with previous reports (Bertuzzi et al. 1999; Hallonet et al. 1999), 
Vax1-/- embryos exhibited lobar HPE associated with narrowing in the maxillary incisor 
region and SMMCI, but the upper lip remained intact (Appendix Fig. 1). In general, the 
mutant skull was slightly smaller than WT with obvious retrusion in the maxillary region. 
The dermatocranium was normal, but multiple defects associated with neurocranial and 
splanchnocranial elements of the chondrocranium were identified. These predominated 
along the ventral midline and varied in severity between mutants (Fig. 1D; Ni-iii). Within 
the nasal cavity, the septum was either hypoplastic or absent, with accompanying 
hypoplasia of the paraseptal cartilages and vomer. There was CP occurring with complete 
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penetrance and associated with defects in the paired maxillary and palatine bones. 
Specifically, a variable circular midline defect affected the body of the pre-maxilla and there 
was hypoplasia of the palatal shelves. The palatal processes of the maxilla were also 
hypoplastic and the palatine bone severely disrupted, lacking palatal processes in many 
cases and exposing the underlying presphenoid bone, which itself lacked medial 
processes and demonstrated a variable level of hypoplasia within the body, the entire bone 
being essentially absent in some mutants. The aural and mandibular regions were normal 
(Appendix Fig. 2). 
The CP phenotype was identifiable in all mutants, communicating with the nasal 
cavity anteriorly and associated with palatal shelves that elevated above the tongue but 
failed to approximate towards the midline (Figure 1E-V). Gross architecture of the mutant 
palatal shelves was normal, with no evidence of disrupted growth or development 
associated with these structures. However, the nasal septum was absent and the 
nasomaxillary region disrupted by a large midline cavity originating from the forebrain and 
extending beneath the floor of the hypothalamus (Fig. 1T green asterix). This structure 
separated the paired VNOs and was demarcated from the oral cavity by only a thin region 
of neuroectoderm in more posterior regions (Fig. 1U; black arrow). Significantly, paired 
VNO’s were present and situated medially-adjacent to the widened nasal cavity. This 
suggested that the CP might be secondary to associated defects within the CNS rather 
than a direct effect of Vax1 function within the palate. 
 
Vax1 does not play a direct role in murine palatogenesis 
In order to further understand the role of Vax1 during palatogenesis we analysed 
expression in the developing palate from E10.5-14.5 using radioactive in situ hybridization. 
Vax1 transcripts were identified in bilateral-restricted regions of ectoderm in the medial 
nasal processes at E10.5, with additional weak expression in midline ectoderm of the 
fronto-nasal process (n=4) (Fig. 2A-C). The domains of expression within the medial nasal 
processes persisted during subsequent growth and fusion with the lateral nasal processes 
 8 
to remain in ectoderm of the presumptive budding vomeronasal organ (VNO) between 
E11.5-12.5 (n=4 and 6, respectively) (Fig. 2D-F) and ultimately, persist in the VNO itself 
(data not shown). Significantly, Vax1 transcripts were not identifiable in either epithelial or 
mesenchymal regions of the secondary palate from E12.5-14.5 (n=3) (Fig. 2G-J), a finding 
that was further verified with RT-PCR (Appendix Fig. 3). However, given the failure of the 
palatal shelves to approximate, we could not definitively rule out a secondary growth defect 
in the mutant and therefore analysed proliferation in these shelves at E13.5 (Fig. 3A-D). 
There were no significant differences in epithelial or mesenchymal proliferation indices 
between WT and Vax1-/- at E13.5 or in linear dimensions of the shelves at E14.5 (data not 
shown). Collectively, these findings suggest that Vax1 does not play a direct role in 
development of the secondary palate and that the associated craniofacial defects 
contributed to the observed CP. 
 
Disrupted proliferation in the early forebrain in the absence of Vax1 function 
The evidence to suggest that Vax1 does not play a direct role in mediating palatogenesis 
prompted us to investigate gross anatomy of the early craniofacial region in WT and Vax1-
/- mice at E11.5 (n=4). Interestingly, we found significant truncation in the ventral forebrain 
region and mid-face of the mutant compared to WT (Fig. 4A-C). We next analysed cell 
proliferation and apoptosis in this region at the same stage. Consistent with the reduced 
linear dimensions in these midline regions, we found significantly reduced proliferation in 
neuroectoderm of the ventral forebrain and mesenchyme within the frontonasal region in 
the mutant when compared to WT (Fig. 4D-F). However, there were no differences 
observed in levels of cell death (data not shown). 
 
Reduced Shh signaling in the early craniofacial region in the absence of Vax1 
function 
There is evidence that Vax1 lies downstream of Hedgehog signaling in several 
developmental models (Hallonet et al. 1999; Kim and Lemke 2006; Take-uchi et al. 2003; 
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Zhao et al. 2010) and Vax1 transcripts are directly adjacent to Shh in the early ventral 
forebrain and medial nasal process (Appendix Fig. 4). Given the presence of lobar HPE in 
Vax1-/- embryos associated with abnormal growth in the ventral forebrain and facial 
midline, we investigated Hedgehog signaling in these regions at E10.5 (n=7 for each 
group) (Fig. 5A-C, G-I; D-F, J-L). There was evidence of a reduced Shh transcriptional 
domain in the midline ventral forebrain of Vax1-/- embryos compared to WT and an 
accompanying reduction of Ptch1 in ventral neuroectoderm and facial mesenchyme. We 
also investigated expression of the direct Shh target Nkx2.1 (Gulacsi and Anderson 2006; 
Pabst et al. 2000) and found reduced expression (Fig. 5M-O; P-R). A more quantitative 
approach was also utilised through qRT-PCR following RNA extraction from dissected 
E10.5 WT and Vax1-/- (n=3 for both groups) embryonic heads (Appendix Fig. 5). mRNA 
levels of Shh and Ptch1 were significantly reduced in Vax1 mutants in comparison to WT. 
Collectively, these data suggest that the craniofacial phenotype associated with loss of 
Vax1 function is directly related to reduced Shh signal transduction in the craniofacial 
region from E10.5. 
 
Loss of Vax1 function in the absence of Gas1 
It has been suggested that numerous genetic and environmental factors may influence 
phenotype in HPE and in some circumstances may be due to mutation in multiple alleles 
(Ming and Muenke 2002). Gas1 encodes a Shh co-receptor, with loss of function 
associated with reduced Shh signaling in the midface and microform HPE (Seppala et al. 
2007; Seppala et al. 2014). We therefore investigated the phenotypic consequences of a 
loss of Vax1 function in a Gas1 mutant background. Although the gross craniofacial 
features of Gas1; Vax1 compound mutant mice did not differ significantly from individual 
single mutants, these mice did demonstrate a complete absence of maxillary incisor 
development (n=4/4), in contrast to single mutants that both have SMMCI (Hallonet et al. 
1999; Seppala et al. 2007). Significantly, the midfacial region was normal in the compound 
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mutants, with paired external nares and an upper lip that remained intact (Appendix Fig. 
6). 
 
Discussion 
Vax1-/- mice have significant defects in the basal forebrain, including absence of the optic 
chiasma and preoptic area, medioventral growth defects, pituitary duplication and lobar 
HPE. There are also facial defects including CP and SMMCI (Bertuzzi et al. 1999; Bharti 
et al. 2011; Hallonet et al. 1999; Taglialatela et al. 2004), whilst in human populations, 
VAX1 is a candidate CLP gene (Butali et al. 2013; de Aquino et al. 2013; de Araujo et al. 
2016; Gowans et al. 2016; Peng et al. 2016; Slavotinek et al. 2012; Wang et al. 2016; Wen 
and Lu 2016; Zawislak et al. 2014) and loss-of-function mutation has been associated with 
micropthamlmia, optic nerve hypoplasia and absence of the corpus callosum (Slavotinek 
et al. 2012). We therefore sought to further understand the role of this transcription factor 
during palatogenesis using the Vax1-/- mouse as a model. Significantly, the observed CP 
appears to be a consequence of the associated gross craniofacial defects, rather than a 
direct effect of Vax1 function. There was no evidence of Vax1 expression in the developing 
palate and no difference in the gross anatomy or levels of proliferation in the palatal shelves 
between WT and mutant. It is most likely that a large midline cavity within the CNS, 
extending from the floor of the hypothalamus through the nasal cavity to the roof of the oral 
cavity, was responsible for the failure of the palatal shelves to approximate in the midline. 
This structure has been described previously and ascribed to the presence of CP, but is 
most likely the cause of this defect (Bertuzzi et al. 1999). 
Vax1-/- mice do have lobar HPE and CP is a common feature of this condition, 
although the precise relationship between these disruptions is poorly understood. In 
common with other mouse models of HPE (Allen et al. 2007; Cole and Krauss 2003; 
Martinelli and Fan 2007; Seppala et al. 2007; Tenzen et al. 2006; Zhang et al. 2011; Zhang 
et al. 2006) Vax1 mutants have reduced Shh signaling in the early craniofacial midline, 
consistent with a downsteam role previously identified in other developmental contexts 
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(Hallonet et al. 1999; Kim and Lemke 2006; Take-uchi et al. 2003; Zhao et al. 2010). 
However, the reduced Shh transcription identified in the ventral forebrain also suggests a 
requirement for Vax1 in maintaining signaling and an important potential feedback loop in 
this region. Interestingly, previous investigations have not identified significant differences 
in Shh or Nkx2.1 expression in the telencephalic neuroectoderm of Vax1 mutants prior to 
E12.5 (Bertuzzi et al. 1999). This might be explained by the fact that these changes are 
subtle; however, we observed them with both in situ hybridization and qRT-PCR analysis 
and the lobar HPE is fully penetrant. The presence of lobar HPE is actually rare in mouse 
mutants (Geng and Oliver 2009) and with the exception of Vax1 (Bertuzzi et al. 1999) has 
only previously been described in mice with loss of Shh co-receptor function (Seppala et 
al. 2014; Zhang et al. 2011). 
 In the mouse, Vax1 is expressed in ectoderm of the medial nasal processes and 
persists as these structures fuse with the lateral nasal processes at the lambdoid junction 
during upper lip formation. Moreover, Vax1 acts as a downstream target of Shh signaling 
in the medial nasal process, potentially acting to restrict Wnt pathway activity, promote cell 
cycle exit and epithelial fusion as lip continuity is established (Kurosaka et al. 2014). It is 
therefore surprising that Vax1-/- mice do not display a cleft lip phenotype. One possible 
explanation is that other factors may compensate for Vax1 function in the early face, 
particularly during the restriction of Wnt signaling activity in the nasal processes (Kurosaka 
et al. 2014). Alternatively, thresholds of activity and genetic background may influence 
phenotypic outcome in the mouse embryo. A closely-related Vax2 gene exists, but 
expression is restricted to the developing eye and targeted disruption of both genes results 
in conversion of the optic nerve to retina, whilst the upper lip remains intact (Mui et al. 
2005). Similarly, gross development of the VNO was normal in Vax1 mutants, despite 
transcripts being strongly expressed in this organ throughout its development. What is 
interesting, is that reducing the levels of Shh signal activity in the mid-facial region by 
generating abrogating Vax1 on a Gas1 mutant background did not result in CLP, although 
the maxillary incisor phenotype did worsen, with agenesis as opposed to SMMCI. 
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We have investigated the role of Vax1 during murine craniofacial development and 
find evidence for reduced Shh signaling in the ventral forebrain associated with reduced 
levels of proliferation, facial truncation and lobar HPE. Despite expression of Vax1 in 
ectoderm of the medial nasal processes the upper lip forms normally in Vax1 mutant mice. 
Moreover, the CP would seem to be the result of disrupted craniofacial development rather 
than a specific function of Vax1. In addition, Vax1; Gas1 mutant mice had a complete 
absence of the maxillary incisors but upper lip formation remained normal. Despite strong 
evidence for VAX1 as a candidate gene for CLP in human populations, this gene is 
seemingly dispensable for normal upper lip development and plays an indirect role in 
palatogenesis in the mouse. 
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Figure legends 
Figure 1 Craniofacial phenotypic analysis of WT and Vax1-/- mice. (A-D) E17.5 
skulls differentially stained for bone and cartilage. (A, B) Lateral (upper panel) and ventral 
(lower panel) views of WT (A) and Vax1-/- (B) skulls demonstrate a smaller size and mid-
facial retrognathia associated with the mutant. In addition, the presence of only a single 
midline maxillary central incisor (red arrow), absence of the nasal septum (green arrow), 
cleft palate (red *) and fenestrations in the region of the spheno-occipital synchondrosis 
(yellow arrow) were also identifiable in the mutant when compared to WT (note that the 
squamosal and frontal bones have been partially removed in the mutant skull). (C, D) 
Highlight of the ventral maxillary region in WT (C) and mutant skulls (D) demonstrating a 
spectrum of increasing severity associated with the midline anomalies seen in the mutant 
(indicated in Di, ii, iii and by the elongated black arrow). In particular, the size of the pre-
maxillary midline fenestration (red arrows) and hypoplasia of the palatal processes of the 
pre-maxilla (orange arrows) and maxilla (pale blue arrows). In addition, the body of the 
palatine bone was also hypoplastic and lacked palatal processes (dark green arrows), 
revealing a severe disruption and increasing hypoplasia associated with the pre-sphenoid 
(violet arrows). Fenestrations were also present in association with the basisphenoid 
(yellow arrows). (E-V) E12.5-15.5 frontal sections of the anterior, middle and posterior 
palatal regions stained with Haematoxylin and Eosin. E12.5 WT (E-G) and Vax1-/- (H-J) 
demonstrating constriction of the frontonasal region (black asterix in H) and normal 
morphology of the palatal shelves in the mutant. E13.5 WT (K-M) and Vax1-/- (N-P) 
demonstrating normal palatal shelf morphology in the mutant. E14.5 WT (Q-S) and Vax1-
/- (T-V) demonstrating the presence of CP in the mutant and a large midline extension of 
the CNS within the nasal cavity (green asterix in T) separated from the oral cavity by a 
layer of neuroectoderm (black arrow in U). 
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Glossary for Fig. 2 and Appendix Fig. 1. ab, alveolar bone of mandible; agp, angular 
process of mandible; als, alisphenoid; bb, basal bone of mandible; bo, basioccipital; bps, 
body of preshenoid; bs, basisphenoid; cbi, crus brevis of incus; cdp, condylar process of 
mandible; cli, crus longus of incus; cna, cupola nasi anterior; crp, coronoid process of 
mandible; c1, first cervical vertebra; eo, exoccipital; fpmx, frontal process of maxilla; fr, 
frontal; go, gonial; in, incus; ip, interparietal; jg, jugal; li, lower incisor; lo, lamina obturans; 
ma, mandible; MC, Meckel’s cartilage; mm, manubrium of malleus; mpps, medial process 
of presphenoid; mx, maxilla; na, nasal; ns, nasal septum; pbm, processus brevis of 
malleus; pca, pars canalicularis; pco, pars cochlearis; pl, palatine; plpps, posterior lateral 
process of presphenoid; pmx, premaxilla; ppmx, palatine process of maxilla; pppl, 
palatine process of palatine; pppx, palatal process of premaxilla; pr, parietal; ps, 
preshenoid; ptg, pterygoid; so, supraoccipital; sp, styloid process; sq, squamosal; st, 
stapes; tr, tympanic ring; ui, upper incisor; vo, vomer; zpsq, zygomatic process 
squamosal. 
 
Figure 2 Expression of Vax1 in the early facial region. (A-H) 35S radioactive in 
situ hybridization on frontal sections through the developing facial region. (A-C) E10.5. (D, 
E) E11.5. (F) E12. (G-J) Digoxigenin-labelled in situ hybridization through the developing 
palatal shelves. (G) E12.5; (H, I) E13.5 frontal and sagittal, respectively; (J) E14.5. 
 
Figure 3 Cell proliferation in the developing palatal shelves at E13.5. (A–B) BrdU 
analysis of E13.5 (A) WT and (B) Vax1–/– palatal shelves. BrdU-positive cells were counted 
in the mesenchyme and epithelium of the middle palatal shelf. For mesenchyme, counting 
was undertaken within an ocular scale grid (black box) orientated at the apex (lower box: 
0.03 mm2) and bend (upper box: 0.015 mm2) regions. For epithelium, counting was 
undertaken within 263 μm and 165 μm lengths of epithelium at the palatal apex (lower 
dotted line) and bend (upper dotted line), respectively. (C, D) Percentage BrdU 
incorporation for (C) epithelium and (D) mesenchyme. A total of 3 WT and 3 Vax1–/– mice 
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were analysed. Student’s t tests were performed to assesses whether the means between 
groups were statistically different from each other. Data is represented as mean and 
standard deviation. P values of less than 0.05 were considered statistically significant. 
Proliferation rates were not statistically different for either region. 
 
Figure 4 Reduced growth in the ventral forebrain and frontonasal region of 
Vax1-/- mice. (A, B) Linear dimensions of E11.5 WT (A) and Vax1-/- (B) embryos at the 
craniofacial midline. Lines were constructed from most anterior point of the isthmus [1] to 
the hypothalamus [2]; from [1] to the most anterior point of the septum [3]; from [3] to the 
optic recess [4] and from [4] to the most anterior-superior point at the fronto-nasal region 
[5]. (C) Statistical analysis showing a significant difference in linear dimensions between 
WT and mutant embryos for all constructed distances. (D, E) BrdU labelling of E10.5 WT 
(D) and Vax1-/- (E) embryos at the craniofacial midline. Percentage positive cells were 
calculated within (0.012 mm2) scale grids at the [1]=septum; [2]=median ganglionic 
eminence; [3]=median eminence; [4]=hypothalamus and [5]=facial mesenchyme. (F) 
Statistical analysis showing a significant difference in percentage proliferating cells 
between WT and mutant embryos at all locations measured. A total of 3 WT and 3 Vax1-/- 
mice were analyzed. Student’s t tests were performed to assesses whether the means 
between groups were statistically different from each other. P values of less than 0.05 were 
considered statistically significant. Data is represented as mean and standard deviation 
(*P<0.05; **P<0.001). 
 
Figure 5 Disrupted Shh signaling in the early forebrain of Vax1-/- embryos. (A-
H) 35S radioactive in situ hybridization on E10.5 sagittal sections through the developing 
craniofacial region of WT (A-C; G-I; M-O; S-U) and Vax1-/- (D-F; J-L; P-R; V-X) embryos. 
(A-F) Shh. (G-L) Ptch1. (M-R) Nkx2.1. 
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Appendix material 
Appendix Figure 1 Histological analysis of the craniofacial midline at E12.5 and 
E15.5. (A, B) At E12.5, Vax1-/- mice have lobar HPE associated with narrowing of the 
anterior maxillary region and SMMCI (red arrow), but the upper lip remains intact. (C, D) 
At E15.5, in more posterior regions of the oral cavity, a duplicated pituitary gland was seen 
in the mutant  extending through the cranial base into the oral cavity (green arrow) (Bharti 
et al. 2011). At E16.5, in the CNS there is fusion of the lateral ventricles and absence of 
the septum (s). 
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Appendix Figure 2 Skeletal preparation of the developing skull at E17.5. (A, B) 
Ventro-lateral highlight of the developing palate (anterior is to the right) in (A) WT and (B) 
Vax1-/-. Note an absence of the nasal septum and hypoplasia of the vomer in the mutant. 
(C, D) Highlight of the ventral pre-sphenoid in (C) WT and (D) Vax1-/-, showing an absence 
of the medial process (purple arrowhead) and hypoplasia of the body (violet arrowhead). 
(E, F; G, H) Comparison of WT middle ear and mandibular skeletal elements, respectively. 
No defects in the gross anatomy of these regions could be identified, although the mutant 
mandible was a little smaller. For full glossary see Figure 1 legend. 
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Appendix Figure 3 RT PCR analysis of Vax1 expression in the frontonasal process 
and palatal shelves. (A) Gel electrophoresis of PCR products derived from RT-PCR 
analysis of Vax1 (lanes 2-5) and β-actin (8-11) expression in craniofacial tissues. (2) E12.5 
and (3) E14.5 frontonasal process; (4) E12.5 and (5) E14.5 palatal shelves; (8) E12.5 and 
(9) E14.5 frontonasal process; (10) E12.5 and (11) E14.5 palatal shelves. Line (6) is the 
negative control and line (12) the positive control (total murine RNA at E12.5). The Vax1 
band has 200 base pairs and the β-actin band 100 base pairs. (1 and 7) 100 base pair 
marker. 
 
 
RNA was isolated from the frontonasal process and palatal shelves of E12.5 and E14.5 WT and 
Vax1-/- embryos using a RNeasy RNA Purification Kit (Qiagen) according to the manufacturer 
protocol. RNA was reverse transcribed and the cDNA used as a template for PCR. β-actin was used 
as a reference gene. The following primer oligonucleotides were used: 
Vax1 F 5’CAAGGAGAGCCGGGAGATCAAG 
Vax1 R 5’TTCTCGGATAGACCCCTTGGC 
RT-PCR Steps Temperature Time Number of 
cycles 
Synthesize 1st Strand DNA      48 oC 45 minutes 1 
Denature template 94 oC 2 minutes 1 
Denaturation 94 oC 30 seconds 35 
Anealling 58 oC 1 minute 35 
Extension 68 oC 2 minutes 35 
 68 oC 7 minutes 1 
   4 oC forever forever 
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Appendix Figure 4 Shh and Vax1 expression in the craniofacial midline. (A-D) 
E11.5 sagittal sections through the developing craniofacial region showing adjacent 
expression of (A, C) Vax1 and (B, D) Shh in neuroectoderm of the ventral forebrain and 
ectoderm of the medial nasal process. 
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Appendix Figure 5 qRT-PCR analysis of Shh signaling activity in embryonic heads 
at E10.5. (A, B) Expression of (A) Shh and (B) Ptch1 in WT and Vax1-/- heads (n=3+3, 
respectively). Students' t-tests were utilized to analyse the relative levels of expression of 
Shh and Ptch1 in both WT and mutant tissue normalized relative (per copy) to the 
housekeeping gene β-Actin (Livak and Schmittgen, 2001). 
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Appendix Figure 6 Vax1; Gas1 compound mutant mice. (A-C) E15.5 gross 
appearance of the midface. (D-F) E15.5 frontal sections through the developing maxillary 
incisor region stained with Haematoxylin and Eosin. (A, D) WT. (B, E) Vax-/-; Gas1+/+. (C, 
F) Vax-/-; Gas-/-. There is a gradation of maxillary incisor phenotype in Gas1; Vax1 
compound mutant mice. In WT mice two maxillary incisor teeth are present in the 
craniofacial midline (D, arrowed), whilst Vax-/-; Gas1+/+ mice have SMMCI (E, black circle) 
and Vax-/-; Gas-/- mice have a complete absence of maxillary incisors (F, black asterix). 
Note the presence of bilateral nares and an intact upper lip in all mice (A-C). 
 
 
 
